Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

It's reasonable to assume than any possible IP

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
shub Member Profile
 
Followed By 12
Posts 1,387
Boards Moderated 0
Alias Born 04/12/11
160x600 placeholder
Advaxis and Biosight announce merger deal to create oncology focused public company Seeking Alpha - 7/6/2021 7:13:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 4:31:06 PM
Advaxis Receives Notice of Delisting from Nasdaq TipRanks - 6/28/2021 9:46:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2021 4:31:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2021 4:16:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/14/2021 4:02:33 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/7/2021 4:31:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2021 4:32:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2021 7:30:58 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/4/2021 7:30:57 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/24/2021 4:01:23 PM
Advaxis updates early stage results for off-the-shelf immunotherapy with Keytruda in lung cancer Seeking Alpha - 5/20/2021 7:07:23 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/19/2021 4:30:51 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/13/2021 4:11:38 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/7/2021 4:31:19 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/28/2021 4:10:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2021 6:06:32 AM
Advaxis shares rise after receiving milestone payment under ADXS-HER2 licensing deal Seeking Alpha - 4/26/2021 8:54:43 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/21/2021 4:31:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/12/2021 5:15:29 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/12/2021 5:10:58 PM
Advaxis proposes $20M registered direct offering Seeking Alpha - 4/12/2021 8:47:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2021 5:29:37 PM
Advaxis to fund earl-stage ADXS-504 study for prostate cancer Seeking Alpha - 4/5/2021 8:43:20 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/2/2021 4:16:18 PM
shub   Wednesday, 09/19/18 02:48:59 PM
Re: jckrdu post# 81794
Post # of 107761 
It's reasonable to assume than any possible IP protection AXAL had has long since expired, along with it's economic value.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences